Assessment of acute lung injury/acute respiratory distress syndrome using B-type brain natriuretic peptide
Authors:
Open Access
- 10 September 2015
- journal article
- research article
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 43 (6) , 802-808
Abstract
Objectives: To investigate the clinical value of B-type natriuretic peptide (BNP) in the assessment of severity and prognosis in acute lung injury/acute respiratory distress syndrome (ALI/ARDS). Methods: Plasma BNP level, arterial blood gases, serum C-reactive protein level, alveolar–arterial oxygen tension difference and oxygenation index were measured in patients with and without ALI/ARDS within 24 h of admission to an intensive care unit. Patients with ALI/ARDS were divided into mild, moderate or severe groups according to the degree of hypoxaemia. Survival >28 days was recorded. Results: A total of 59 patients with ALI/ARDS and 14 patients without ALI/ARDS were included in the study. Of the patients with ALI/ARDS, 18 had mild hypoxaemia, 20 had moderate hypoxaemia and 21 had severe hypoxaemia. The mean ± SD BNP level was significantly higher in all three ALI/ARDS groups (92.41 ± 28.19 pg/ml, 170.64 ± 57.34 pg/ml and 239.06 ± 59.62 pg/ml, respectively, in the mild, moderate and severe groups) than in the non-ALI/ARDS group (47.27 ± 19.63 pg/ml); the increase in BNP level with increasing severity was also statistically significant. When divided according to outcome, the BNP level in the death group (267.07 ± 45.06 pg/ml) was significantly higher than in the survival group (128.99 ± 45.42 pg/ml). Conclusions: The BNP level may be of value in evaluating severity and prognosis in patients with ALI/ARDS.Keywords
This publication has 24 references indexed in Scilit:
- Comparison of the diagnostic and prognostic values of B-type and atrial-type natriuretic peptides in acute heart failureInternational Journal of Cardiology, 2013
- Concentration of Natriuretic Peptides in Patients Suffering from Idiopathic Arterial Hypertension and Left Ventricular Diastolic Dysfunction Confirmed by EchocardiographyClinical and Experimental Hypertension, 2012
- Brain type natriuretic peptide (BNP)—A marker of new millennium in diagnosis of congestive heart failureIndian Journal of Clinical Biochemistry, 2007
- Association of Left-Heart Dysfunction with Severe Exacerbation of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Utility of B-Type Natriuretic Peptide and N-terminal Pro B-Type Natriuretic Peptide in Evaluation of Respiratory Failure in Critically Ill PatientsChest, 2005
- B-type natriuretic peptide in cardiovascular diseaseThe Lancet, 2003
- Natriuretic peptides in detection of heart failureThe Lancet, 1998
- The American-European Consensus Conference On Ards. Definitions, Mechanisms, Relevant Outcomes, And Clinical Trial CoordinationAmerican Journal of Respiratory and Critical Care Medicine, 1994
- A new natriuretic peptide in porcine brainNature, 1988
- Pulmonary microthrombosis in severe adult respiratory distress syndromeCritical Care Medicine, 1988